Kidney transplantation and infection

被引:0
作者
Witzke O. [1 ]
机构
[1] Klinik für Nephrologie, Universitätsklinikum Essen, Hufelandstr. 55, Essen
来源
Der Nephrologe | 2015年 / 10卷 / 5期
关键词
D O I
10.1007/s11560-015-1004-3
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:409 / 413
页数:4
相关论文
共 11 条
  • [1] Opelz G., Dohler B., Association of HLA mismatch with death with a functioning graft after kidney transplantation: a collaborative transplant study report, Am J Transplant, 12, pp. 3031-3038, (2012)
  • [2] Sagedal S., Hartmann A., Nordal K.P., Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival, Kidney Int, 66, pp. 329-337, (2004)
  • [3] Kliem V., Fricke L., Wollbrink T., Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial, Am J Transplant, 8, pp. 975-983, (2008)
  • [4] Desai R., Collett D., Watson C.J.E., Impact of cytomegalovirus on long-term mortality and cancer risk after organ transplantation, Transplantation [Epub ahead of print], (2015)
  • [5] Hodson E.M., Ladhani M., Webster A.C., Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients, Cochrane Database Syst Rev 2:CD003774, (2013)
  • [6] Owers D.S., Webster A.C., Strippoli G.F.M., Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients, Cochrane Database Syst Rev 2:CD005133, (2013)
  • [7] Couzi L., Helou S., Bachelet T., High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapy, Am J Transplant, 12, pp. 202-209, (2012)
  • [8] Elfadawy N., Flechner S.M., Schold J.D., Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation, Clin J Am Soc Nephrol, 9, pp. 1-10, (2014)
  • [9] Pham P.T., Schaenman J., Pham P.C., BK virus infection following kidney transplantation: an overview of risk factors, screening strategies, and therapeutic interventions, Curr Opin Organ Transplant, 19, pp. 401-412, (2014)
  • [10] Lee B.T., Gabardi S., Grafals M., Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial, Clin J Am Soc Nephrol, 9, pp. 583-589, (2014)